Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis

Saved in:
Bibliographic Details
Main Authors: Rita Spathis, Deeva Robles Kuriplach, Sabrina Narvesen, Matthew Eybs, Karen Huang, Steven Torres, Madison King, Elizabeth Bagley, Pia Elustondo, Michael W. Lawlor, Kanneboyina Nagaraju, Melissa Morales
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593193/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850057948858941440
author Rita Spathis
Deeva Robles Kuriplach
Sabrina Narvesen
Matthew Eybs
Karen Huang
Steven Torres
Madison King
Elizabeth Bagley
Pia Elustondo
Michael W. Lawlor
Kanneboyina Nagaraju
Melissa Morales
author_facet Rita Spathis
Deeva Robles Kuriplach
Sabrina Narvesen
Matthew Eybs
Karen Huang
Steven Torres
Madison King
Elizabeth Bagley
Pia Elustondo
Michael W. Lawlor
Kanneboyina Nagaraju
Melissa Morales
author_sort Rita Spathis
collection DOAJ
format Article
id doaj-art-4f3bb56595f649f5982012aee74fe196
institution DOAJ
issn 1664-3224
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-4f3bb56595f649f5982012aee74fe1962025-08-20T02:51:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-03-011610.3389/fimmu.2025.15931931593193Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosisRita Spathis0Deeva Robles Kuriplach1Sabrina Narvesen2Matthew Eybs3Karen Huang4Steven Torres5Madison King6Elizabeth Bagley7Pia Elustondo8Michael W. Lawlor9Kanneboyina Nagaraju10Melissa Morales11Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesAGADA Biosciences, Halifax, NS, CanadaDepartment of Pathology & Laboratory Medicine, Medical College of Wisconsin and Diverge Translational Science Laboratory, Milwaukee, WI, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United StatesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1593193/fullAAV9mdxDuchenne muscular dystrophyDMDgene therapyimmune response
spellingShingle Rita Spathis
Deeva Robles Kuriplach
Sabrina Narvesen
Matthew Eybs
Karen Huang
Steven Torres
Madison King
Elizabeth Bagley
Pia Elustondo
Michael W. Lawlor
Kanneboyina Nagaraju
Melissa Morales
Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
Frontiers in Immunology
AAV9
mdx
Duchenne muscular dystrophy
DMD
gene therapy
immune response
title Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
title_full Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
title_fullStr Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
title_full_unstemmed Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
title_short Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
title_sort corrigendum enhancing aav microdystrophin gene therapy after repeat dosing by blocking phagocytosis
topic AAV9
mdx
Duchenne muscular dystrophy
DMD
gene therapy
immune response
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593193/full
work_keys_str_mv AT ritaspathis corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT deevarobleskuriplach corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT sabrinanarvesen corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT mattheweybs corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT karenhuang corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT steventorres corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT madisonking corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT elizabethbagley corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT piaelustondo corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT michaelwlawlor corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT kanneboyinanagaraju corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis
AT melissamorales corrigendumenhancingaavmicrodystrophingenetherapyafterrepeatdosingbyblockingphagocytosis